Skip to Main content Skip to Navigation
Journal articles

The lung in hereditary hemorrhagic telangiectasia

Abstract : Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular disorder with an estimated prevalence of 1 in 6,000, characterized by recurrent epistaxis, cutaneous telangiectasia, and arteriovenous malformations (AVMs) that affect many organs including the lungs, gastrointestinal tract, liver, and brain. Its diagnosis is based on the Curacao criteria, and is considered definite if at least 3 of the 4 following criteria are fulfilled: (1) spontaneous and recurrent epistaxis, (2) telangiectasia, (3) a family history, and (4) pulmonary, liver, cerebral, spinal, or gastrointestinal AVMs. The focus of this review is on delineating how HHT affects the lung.
Complete list of metadata
Contributor : Migration Prodinra Connect in order to contact the contributor
Submitted on : Monday, May 25, 2020 - 11:15:36 PM
Last modification on : Tuesday, January 18, 2022 - 2:26:06 PM

Links full text




Sophie Dupuis-Girod, Vincent Cottin, C. L. Shovlin. The lung in hereditary hemorrhagic telangiectasia. Respiration, Karger, 2017, 94 (4), pp.315-330. ⟨10.1159/000479632⟩. ⟨hal-02620517⟩



Les métriques sont temporairement indisponibles